TABLE 3.
Unadjusted Ms, SDs, and minimum–maximum values; ANCOVA p-values; and effect sizes for diagnostic group comparisons
| Group |
||||||
|---|---|---|---|---|---|---|
| Dependent variable |
DS (n=24) |
FXS (n=22) |
TD (n=27) |
p | da | |
| PPVT-3 | .06 | DS/FXS: −0.85 | ||||
| Mean | 69.00 | 89.77 | 77.48 | DS/TD: −0.36 | ||
| SD | 21.42 | 26.98 | 25.21 | FXS/TD: 0.47 | ||
| Min–Max | 12–107 | 55–155 | 24–125 | |||
| TROG-2 | <.001* | DS/FXS: −0.50 | ||||
| Mean | 2.63 | 3.95 | 6.78 | DS/TD: −1.36* | ||
| SD | 1.58 | 2.75 | 3.64 | FXS/TD: −0.88* | ||
| Min–Max | 0–6 | 0–10 | 0–15 | |||
| EVT-2 | .15 | DS/FXS: −0.77 | ||||
| Mean | 47.58 | 56.36 | 52.96 | DS/TD: −0.42 | ||
| SD | 10.23 | 14.20 | 11.88 | FXS/TD: 0.29 | ||
| Min–Max | 32–74 | 37–89 | 36–73 | |||
| CASL-SC | <.001* | DS/FXS: −1.14* | ||||
| Mean | 6.75 | 14.36 | 17.11 | DS/TD: −1.46* | ||
| SD | 6.45 | 7.93 | 6.74 | FXS/TD: −0.33 | ||
| Min–Max | 0–26 | 1–30 | 2–32 | |||
| Conversational | <.001* | DS/FXS: −0.75 | ||||
| MLU | DS/TD: −2.00* | |||||
| Mean | 3.47 | 4.46 | 5.80 | FXS/TD: −1.00* | ||
| SD | 1.15 | 1.48 | 1.18 | |||
| Min–Max | 1.84–5.89 | 2.20–7.05 | 3.30–7.87 | |||
a
TROG-2, EVT-2 and CASL-SC calculations based on transformed values;
*
statistically significant with Bonferroni correction.